Literature DB >> 15206107

Ruthenium anticancer drugs.

Enzo Alessio1, Giovanni Mestroni, Alberta Bergamo, Gianni Sava.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15206107

Source DB:  PubMed          Journal:  Met Ions Biol Syst        ISSN: 0161-5149


× No keyword cloud information.
  8 in total

Review 1.  Redox activation of metal-based prodrugs as a strategy for drug delivery.

Authors:  Nora Graf; Stephen J Lippard
Journal:  Adv Drug Deliv Rev       Date:  2012-01-25       Impact factor: 15.470

2.  Synthesis, characterization, and reaction pathways for the formation of a GMP adduct of a cytotoxic thiocyanato ruthenium arene complex.

Authors:  Fuyi Wang; Abraha Habtemariam; Erwin P L van der Geer; Robert J Deeth; Robert Gould; Simon Parsons; Peter J Sadler
Journal:  J Biol Inorg Chem       Date:  2009-06-05       Impact factor: 3.358

3.  Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy.

Authors:  Suzanne Leijen; Sjaak A Burgers; Paul Baas; Dick Pluim; Matthijs Tibben; Erik van Werkhoven; Enzo Alessio; Gianni Sava; Jos H Beijnen; Jan H M Schellens
Journal:  Invest New Drugs       Date:  2014-10-25       Impact factor: 3.850

4.  Synthesis, characterization and antitumor mechanism investigation of ruthenium(II) polypyridyl complexes with artesunate moiety.

Authors:  Bi-Chun Chen; Jun-Jian Lu; Ning Jiang; Xiu-Rong Ma; Rong-Tao Li; Rui-Rong Ye
Journal:  J Biol Inorg Chem       Date:  2021-09-20       Impact factor: 3.358

5.  Catch and Release Photosensitizers: Combining Dual-Action Ruthenium Complexes with Protease Inactivation for Targeting Invasive Cancers.

Authors:  Karan Arora; Mackenzie Herroon; Malik H Al-Afyouni; Nicholas P Toupin; Thomas N Rohrabaugh; Lauren M Loftus; Izabela Podgorski; Claudia Turro; Jeremy J Kodanko
Journal:  J Am Chem Soc       Date:  2018-10-22       Impact factor: 15.419

6.  Cisplatin and siRNA interference with structure and function of Wnt-5a mRNA: design and in vitro evaluation of targeting AU-rich elements in the 3' UTR.

Authors:  Margareta Hägerlöf; Pal Papsai; Hanna K Hedman; Ute Jungwirth; Veronika Jenei; Sofi K C Elmroth
Journal:  J Biol Inorg Chem       Date:  2007-12-06       Impact factor: 3.358

7.  Antimetastatic activity of novel ruthenium (III) pyridine complexes.

Authors:  Liwei Gu; Xiaodong Li; Qingsen Ran; Chen Kang; Canghai Lee; Jianying Shen
Journal:  Cancer Med       Date:  2016-09-07       Impact factor: 4.452

8.  Photosensitive Ru(II) Complexes as Inhibitors of the Major Human Drug Metabolizing Enzyme CYP3A4.

Authors:  Nicholas Toupin; Sean J Steinke; Sandeep Nadella; Ao Li; Thomas N Rohrabaugh; Eric R Samuels; Claudia Turro; Irina F Sevrioukova; Jeremy J Kodanko
Journal:  J Am Chem Soc       Date:  2021-06-10       Impact factor: 16.383

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.